Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spyre Therapeutics (SYRE) Tax Rate (2021 - 2025)

Spyre Therapeutics (SYRE) has disclosed Tax Rate for 5 consecutive years, with 0.03% as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Tax Rate rose 11.0% year-over-year to 0.03%, compared with a TTM value of 0.01% through Dec 2025, up 3.0%, and an annual FY2025 reading of 0.01%, up 3.0% over the prior year.
  • Tax Rate was 0.03% for Q1 2025 at Spyre Therapeutics, up from 0.0% in the prior quarter.
  • Across five years, Tax Rate topped out at 1.13% in Q3 2022 and bottomed at 0.2% in Q4 2022.
  • Average Tax Rate over 5 years is 0.06%, with a median of 0.02% recorded in 2023.
  • The sharpest move saw Tax Rate surged 126bps in 2022, then crashed -114bps in 2023.
  • Year by year, Tax Rate stood at 0.11% in 2021, then tumbled by -80bps to 0.2% in 2022, then skyrocketed by 96bps to 0.01% in 2023, then soared by 76bps to 0.0% in 2024, then skyrocketed by 1985bps to 0.03% in 2025.
  • Business Quant data shows Tax Rate for SYRE at 0.03% in Q1 2025, 0.0% in Q4 2024, and 0.03% in Q3 2024.